CD8 derivatives and methods of use for cellular modulation and e

Details CD8 derivatives and methods of use for cellular modulation and e CD8 derivatives and methods of use for cellular modulation and e

1993-08-24

1997-02-11

Cunningham, Thomas M.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

4241841, 4242781, 424 931, 530395, 530868, A61K 3900, A61K 4500

Patent

active

056018282

ABSTRACT:
Specific and nonspecific immunomodulation, enhancement of cellular engraftment, and modulation of nonimmune cells are achieved by using various membrane-binding and soluble CD8 compositions.

REFERENCES:
patent: 5242687 (1993-09-01), Tykocinski et al.
Dembie, Z., et al., Nature 326:510-511 (1987), "Transfection of the CD8 gene enhances T-cell recognition".
Hambor, J. E., et al., J. Exp. Med. 168:1237-1245 (Oct., 1988) "Functional Consequences of anti-sense RNA-mediated inhibition of CD8 surface expression in a human T cell clone".
Kaplan et al., Proc. Natl. Acad. Sci. USA, 86:8512-15, 1988.
Hambour et al., J. Exp. Med. 168:1237-45, 1988.
Rosenstein et al., J. Exp. Med. 169;149-160, 1989.
Littman, Ann. Rev. Immunology, 5:561-84, 1987.
Fink et al., Ann. Rev. Immunology, 6:115-37, 1988.
Bierer et al., Ann. Rev. Immunology 7:579-99, 1989.
Furguson, Ann. Rev. Biochemistry, 57:285-295, 1988.
Tykocinski et al., Proc. Natl. Acad. Sci., USA, 85:3555-3559, 1988.
Fasel et al., Proc. Natl. Acad. Sci., USA, 86:6858-62, 1989.
Littman et al., Cell 40:237-246, 1985.
Abrams et al., AIDS/HIV Experimental Treatment Directory, vol. 2(2), p. 100-1.
Rammensee, Intern. Rev. Immunol. 4:1754-191, 1989.
Claesson, Cellular Immunology 109:360-370, 1987.
Fasel et al., Proc. Natl. Acad. Sci., USA, 86:6858, 1989.
Melchers et al., Scand. J. Immunol. 30:99-109, 1989.
Green et al., Ann. Rev. Immunol 1:43963, 1983.
Fink et al., J. Exp. Med. 157:141-154, 1983.
Kung et al., PCT WO 87/05912, Oct. 8, 1987, (T-Cell Sciences).
Capon et al., U.S. Pat. 5,116,964, issued May 1992, class: 536.27.
Dustin et al., U.S. Pat. 5,071,964, issued Dec. 1991, class 530.395.
Medof et al., J. Exp. Med. 160:1558-1578, 1984, "Inhibition of Complement activation of the surface of cells after incorporation of decay-accelerating factor".
Lenschow et al., Science 257:789-792, 1992, "Longterm survival of xenogenic pancreatic islet grafts inducef by CTLA4-Ig".
Tan et al., J. Exp. Med. 177:165-173 (1993), "Induction of alloantigen hyporesponsiveness in human T-lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1".
Mueller et al., Ann. Rev. Immunol. 77:445-480, 1989, "Clonal expansion versus functional clonal inactivation".
Norton et al., J. Immunology, 149:1556-1561, Sep., 1992, "The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells".
Rosenberg, Annu. Rev. Immunol. 1992 10:333-358, "Cellular basis of skin allograft rejection".
Wecker et al., Curr. Opinion in Immunol. 1992 4:561-466, "Cellular mechanisms of rejection".
Cohen, Science 257:751 (1992), "Mounting a targeted strike on unwanted immune responses".
Auchincloss et al., "Transplantation and Graft Rejection" in Fundamental Immunology (W. F. Paul ed.), 1989, Raven Press.
Jiang et al., Science 256:1213-1215, 1992, "Role of CD8 +T cells . . . ".
Koh et al., Science 256:1210-1213, 1992, "Less mortality . . . ".
Vremec et al., J. Exp. Med. 176, pp. 47-58, 1992.
Hambor et al., International Immonology 2(9):879, 1990.
Tomonari et al., International Immunology 2(12): 1189, 1990.
Hambor et al., J. Immunology, 145:1646, 1990 "CD8 Functionsas As An Inhibitory".
Miller, Immunology Today 7(4):112, 1986.
Vitiello et al., J. Immunology, 143:1512, 1989.
Scala et al., J. Immunology, 134(5):3049, 1985.
Norment et al., EMBO Journal, 7(10):3433, 1988.
Phillips et al., J. Exp. Med. 161:1464, 1985.

Affiliated with

Also associated with

Rating

CD8 derivatives and methods of use for cellular modulation and e does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CD8 derivatives and methods of use for cellular modulation and e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CD8 derivatives and methods of use for cellular modulation and e will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-339803